Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsHome visits — once common and now resurging — flip the dynamic, as the clinician becomes a guest in the patient's home. Experts say as both learn more about each other than is possible in-office, trust can build.
Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Direct primary care is more than medicine. Dr Rajdeep Dhami shares what physicians should know before starting DPC, from operations and branding to boundaries and community.
1.
A large study found that monolayers were superior in detecting cancer.
2.
Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.
3.
MRD Tied to PFS in Lymphoma Patients on Epcoritamab
4.
According to research, the mineralization of the bone matrix controls the growth of tumor cells.
5.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
1.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
2.
The Lung Cancer Shift: From Reactive Treatment to Proactive Precision Medicine
3.
Tumor Microenvironment Secretome Mapping in Cancer Biology
4.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
5.
Immune Ecosystem Remodeling Within Solid Tumor Niches
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
2.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge